Prof. Peter Schmid, Consultant Medical Oncologist
Prof. Peter Schmid
Consultant Medical Oncologist
Prof. Peter Schmid MD PhD FRCP
Consultant Medical Oncologist
Prof. Peter Schmid
Consultant Medical Oncologist MD PhD FRCP
Areas of expertise
- Breast oncology
- Dealing with early breast lumps
- Lung cancer
- Immunotherapy
- Triple negative breast cancer
Recommendations for Prof. Schmid
These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.
Recommended by:
Make an appointment
Address
-
LOC at Chelsea
102 Sydney Street, Chelsea, London, SW3 6NJ
-
LOC - Leaders in Oncology Care
95-97 Harley Street, London, W1G 6AF
-
London Bridge Hospital
27 Tooley Street, London, SE1 2PR
-
The Wellington Hospital
Wellington Place, St John's Wood, London, NW8 9LE
About Prof. Peter Schmid
GMC number: 6111181
Year qualified: 1997
Place of primary qualification: Technische Universität München
Prof. Peter Schmid is an internationally renowned breast cancer oncologist. He serves as the clinical director of the Breast Cancer Centre at St. Bartholomew’s Hospital in London and holds the position of Chair in Cancer Medicine at Barts Cancer Institute, Queen Mary University London.
Prof. Schmid’s work focuses on integrating novel therapies, grounded in the biology of cancer, with high-quality care for women with breast cancer. His areas of expertise include the diagnosis, treatment, and optimal recovery of breast cancer patients. He has a particular interest in triple-negative breast cancer, young women with breast cancer, pregnancy-associated breast cancer, and fertility-related issues.
Prof. Schmid is dedicated to patient-centered, holistic care. He tailors treatments to individual patients, considering biological factors, personal preferences, and continuous review of care outcomes. He operates within a multidisciplinary team, ensuring comprehensive support for patients, including breast care nurse assistance.
Prof. Schmid is also passionate about patient-doctor communication. He has led a training program for oncologists and oncology nurses for many years, emphasizing the importance of effective communication in patient care. His research aims to improve the treatment of women with breast cancer by developing more effective and less toxic therapies.
In his role, Prof. Schmid is committed to advancing the field of breast cancer treatment and ensuring the best possible outcomes for his patients.
Areas of expertise
- Breast oncology
- Dealing with early breast lumps
- Lung cancer
- Immunotherapy
- Triple negative breast cancer
Professional memberships
Articles by Prof. Peter Schmid
C45the role of ribociclib in hormone receptor-positive (hr+), human epidermal growth factor receptor 2-negative (her2–) early breast cancer: the earlee adjuvant clinical trials program
Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (fergi): a randomised, double-blind, placebo-controlled, phase 2 trial
Systematic review of the impact of breast-conserving surgery on cancer outcomes of multiple ipsilateral breast cancers